Today: 7 February 2026
Subscribe
Browse Category

Healthcare Stocks News 14 December 2025 - 27 December 2025

Healthcare Stocks Outlook: Year-End Rotation, J&J’s Eczema Setback, and Managed-Care Scrutiny Shape the Setup Before Monday’s Open

Healthcare Stocks Outlook: Year-End Rotation, J&J’s Eczema Setback, and Managed-Care Scrutiny Shape the Setup Before Monday’s Open

NEW YORK, Dec. 27, 2025, 12:57 p.m. ET — Market closed (weekend) Healthcare stocks are heading into the final trading days of 2025 with a rare mix of “defensive” support and headline-driven volatility—exactly the combination that can matter most when liquidity is thin and investors are rebalancing portfolios into year-end. U.S. stock markets are shut today, but Friday’s post-Christmas session left a clear message: the broader market is still hovering near record levels, and investors have been widening their focus beyond mega-cap technology—an environment that can favor large-cap healthcare even as biotech remains more catalyst-sensitive. Reuters+1 Where healthcare stocks stand
27 December 2025
····
HCA Healthcare (HCA) Stock After Hours on Dec. 24, 2025: What Happened After the Bell and What to Know Before Markets Reopen

HCA Healthcare (HCA) Stock After Hours on Dec. 24, 2025: What Happened After the Bell and What to Know Before Markets Reopen

HCA Healthcare, Inc. (NYSE: HCA) ended the holiday-shortened Christmas Eve session essentially flat—but the tape got a little noisier once regular trading ended. Just as important for investors: U.S. stock markets are closed on Thursday, Dec. 25 (Christmas Day), so there is no “tomorrow open” in the usual sense. The next regular U.S. equity session is Friday, Dec. 26, 2025, following the standard holiday schedule. Fortune Below is what moved (and what didn’t), the key numbers from today’s trading, the latest analyst outlook, and the catalysts worth tracking before the next session begins. HCA stock price check: close, after-hours move,
25 December 2025
·····
Healthcare Stocks Outlook (Dec. 21, 2025): Drug-Price Deals, ACA Premium Shock, and 2026 Catalysts Investors Are Watching

Healthcare Stocks Outlook (Dec. 21, 2025): Drug-Price Deals, ACA Premium Shock, and 2026 Catalysts Investors Are Watching

Sunday, December 21, 2025 — With U.S. markets heading into a holiday-shortened final trading stretch, healthcare stocks are back in focus as investors weigh a year-end “Santa rally” against a fast-moving policy backdrop that is unusually direct for the sector: drugmakers cutting prices through White House deals, insurers staring down a subsidy cliff tied to the Affordable Care Act (ACA), and a new wave of biotech dealmaking and capital-markets activity that is reopening risk appetite. Reuters+4Reuters+4The Washington Post+4 Below is a comprehensive roundup of the key healthcare stock news, forecasts, and sector analyses circulating on December 21, 2025, along with
21 December 2025
···
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific Corporation (NYSE: BSX) stock is trading lower in Friday’s session, with shares at $95.76 as of 17:30 UTC on December 19, 2025 (down 0.36% on the day). The stock’s intraday range has run from $95.64 to $97.24, after opening at $96.85 on volume of roughly 4.49 million shares at the time of this update. The move comes one day after BSX closed at $96.11 on Thursday, December 18, extending a three-session winning streak and drawing heavier-than-usual trading activity. MarketWatch reported Thursday’s volume near 15.6 million shares, above a 50‑day average around 9.0 million, while noting the stock remained
19 December 2025
·····
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems, Inc. (NYSE: INSP) stock tumbled sharply on Thursday, December 18, 2025, after a key Medicare coding tailwind that had fueled recent optimism suddenly looked far less certain. By early afternoon in the U.S. session, INSP was down in the mid-to-high teens, reflecting investor anxiety that a reimbursement “upgrade” tied to a specific billing code may not stick—at least not in the clean, nationwide way many had modeled. MarketBeat What happened to INSP stock on 18.12.2025? The immediate catalyst: two Medicare Administrative Contractors (MACs)—CGS and Noridian—reportedly pulled CPT code 64568 for hypoglossal nerve stimulation (HGNS) and redirected billing
18 December 2025
····
RadNet (RDNT) Stock Drops After Hunterbrook Short Report: News, Analyst Forecasts, and What to Watch on Dec. 16, 2025

RadNet (RDNT) Stock Drops After Hunterbrook Short Report: News, Analyst Forecasts, and What to Watch on Dec. 16, 2025

RadNet, Inc. (NASDAQ: RDNT) stock traded sharply lower Tuesday, Dec. 16, 2025, after a newly published short-seller report from Hunterbrook Capital questioned the durability of the company’s artificial intelligence narrative and the way investors interpret several key growth metrics. By the end of the session window covered in market data, RDNT was trading around the high-$60s after printing an intraday low in the low-$60s. Investing.com Nigeria+1 The selloff lands at an awkward time for RadNet: the company has been reporting double-digit revenue growth in its core imaging business, investing heavily in Digital Health/AI, and earning a generally positive analyst posture
16 December 2025
····
Boston Scientific (BSX) Stock News on Dec. 16, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Boston Scientific (BSX) Stock News on Dec. 16, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Tuesday, December 16, 2025, as the stock trades in the low-$90s—well below its September highs—while Wall Street’s broader view remains notably upbeat on the medical-device leader’s growth outlook. As of the latest available market data, BSX traded around $92.23 on Dec. 16, with an intraday range of roughly $90.44 to $92.77. That places the stock about 16% below its 52‑week high of $109.50 and roughly 7% above its 52‑week low of $85.98, highlighting how sharply sentiment has cooled since the late-summer peak even as fundamentals have stayed resilient. MarketBeat
16 December 2025
·····
Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus on Tuesday, December 16, 2025, after a strong rebound in the prior session and a fresh wave of market commentary ranging from technical-analysis signals to institutional-filings headlines and updated Wall Street expectations. As of late morning U.S. trading, ISRG traded around $548–$549, down roughly 2% on the day, valuing the surgical-robotics leader at about $194 billion in market capitalization. StockAnalysis+1 Below is a comprehensive, publication-ready roundup of the news, forecasts, and analyses circulating on 16.12.2025, plus the key catalysts investors are watching into early 2026. ISRG stock price today: a pullback
16 December 2025
·····
UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 16, 2025

UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 16, 2025

December 16, 2025 UnitedHealth Group Incorporated (NYSE: UNH) is back in focus for investors as the health insurance giant heads into a catalyst-heavy stretch: a dividend payment landing today, a confirmed date for full‑year 2025 results and 2026 guidance, and a drumbeat of regulatory and legal headlines tied to its Optum business and Medicare-related scrutiny. As of 15:44 UTC on Dec. 16, UNH shares were trading around $337.21, down about 1.14% on the session. Investors tracking intraday action saw UNH trade within a relatively tight band early Tuesday, with one real-time quote showing a day’s range near $335.54 to $340.99.
16 December 2025
·····
UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group Incorporated (NYSE: UNH) is back in the spotlight as 2025 winds down—caught between “defensive” sector rotation, fresh legal headlines, and a fast-approaching earnings and guidance reset that could shape sentiment for 2026. As of 15:27 UTC on Monday, December 15, 2025, UNH stock traded at $337.51, down about 1.27% on the day, after moving between $337.07 and $344.84. Trading volume was about 1.75 million shares at that point in the session. That price action may look routine, but the story underneath isn’t. UnitedHealth is navigating a complicated mix of: Below is a comprehensive roundup of the most current
15 December 2025
·····
Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare Inc. (NASDAQ: IXHL) is back on traders’ radar heading into mid-December, with the stock hovering around $0.42 in early Monday pricing on December 15, 2025, after closing near $0.40 in the prior session. The renewed attention isn’t coming out of nowhere. Over the past several weeks, Incannex has stacked up a series of developments that matter to speculative biotech investors: a U.S. FDA Fast Track designation for its lead obstructive sleep apnea (OSA) program, a Nasdaq minimum bid-price compliance deadline now pushed into 2026, and fresh research commentary from at least one boutique coverage firm—along with a mixed
15 December 2025
·····
Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

As U.S. markets head into Monday’s open (Dec. 15, 2025), Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus after a busy stretch of headlines spanning new FDA clearances, competitive pressure rising, and fresh Wall Street calls. Shares most recently traded around $542.32 (based on the latest available pricing ahead of Monday’s session). Below is what investors and watchlists are likely keying on before the opening bell. 1) The newest catalyst: FDA expands da Vinci SP indications (Dec. 10) Intuitive’s most recent company-driven headline is a new U.S. FDA clearance for its da Vinci Single Port (SP) system—expanding indicated use
14 December 2025
····
1 2 3 4 5 6

Stock Market Today

Halma share price: Friday’s lift sets up what investors watch next week

Halma share price: Friday’s lift sets up what investors watch next week

7 February 2026
Halma shares closed up 0.7% at 3,548 pence on Friday, valuing the group at about £13.4 billion. The Bank of England held rates at 3.75% in a split vote, keeping rate-cut speculation in focus. Halma’s next trading update is set for March 12. The FTSE 100 ended the week up 0.6%, lifted by bank stocks.
Diageo share price slips into the weekend as investors eye Feb. 25 results

Diageo share price slips into the weekend as investors eye Feb. 25 results

7 February 2026
Diageo shares closed down 1.48% at 1,760 pence on Friday, trailing a 0.59% gain in the FTSE 100. An updated analyst consensus points to a 2.0% fall in first-half organic net sales ahead of interim results due Feb. 25. Trading volume was light, and the stock remains over 22% below its 52-week high.
National Grid share price: what to know before London reopens after BoE signal

National Grid share price: what to know before London reopens after BoE signal

7 February 2026
National Grid shares closed at 1,285 pence in London on Friday, up 0.23%. The Bank of England held rates at 3.75% after a close vote, signaling possible cuts if inflation falls. National Grid announced a wireless power transmission study with Space Solar and marked five years of IFA2 interconnector operations. Its U.S. ADR ended at $88.06, up $1.17.
BAE Systems share price rises into weekend — what to watch before Monday’s London open

BAE Systems share price rises into weekend — what to watch before Monday’s London open

7 February 2026
BAE Systems shares closed up 1.2% at 1,879 pence on Friday, tracking gains in European defence stocks. The company’s market value stands near £54.8 billion. Investors await BAE’s full-year results on Feb. 18 for updates on cash returns and orders. GXO Logistics renewed and expanded its contract to support BAE’s Type 26 frigate program in Scotland.
Go toTop